within Pharmacolibrary.Drugs.N_NervousSystem.N07B_DrugsUsedInAddictiveDisorders.N07BB05_Nalmefene;

model Nalmefene
  extends Pharmacolibrary.Drugs.ATC.N.N07BB05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N07BB05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Nalmefene is an opioid receptor modulator, primarily used to reduce alcohol consumption in adults with alcohol dependence. It acts as an antagonist at the mu and delta opioid receptors and a partial agonist at the kappa opioid receptor. It is approved in several countries (e.g., in the EU) as a prescription medication for the reduction of alcohol consumption in patients with alcohol dependence.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Bergasa, NV, et al., &amp; Jones, EA (1998). Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. <i>Hepatology (Baltimore, Md.)</i> 27(3) 679–684. DOI:<a href=&quot;https://doi.org/10.1002/hep.510270307&quot;>10.1002/hep.510270307</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9500694/&quot;>https://pubmed.ncbi.nlm.nih.gov/9500694</a></p></li><li><p>Kyhl, LE, et al., &amp; Areberg, J (2016). Population pharmacokinetics of nalmefene in healthy subjects and its relation to μ-opioid receptor occupancy. <i>British journal of clinical pharmacology</i> 81(2) 290–300. DOI:<a href=&quot;https://doi.org/10.1111/bcp.12805&quot;>10.1111/bcp.12805</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26483076/&quot;>https://pubmed.ncbi.nlm.nih.gov/26483076</a></p></li><li><p>Dixon, R, et al., &amp; Weidler, D (1987). Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist. <i>Journal of clinical pharmacology</i> 27(3) 233–239. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1987.tb02191.x&quot;>10.1002/j.1552-4604.1987.tb02191.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3680580/&quot;>https://pubmed.ncbi.nlm.nih.gov/3680580</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Nalmefene;
